Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safest Choice of Antihypertensive Regimen for Postpartum Hypertension: A Randomized Control Trial (SCARPH)

NCT05551104 is registered in ClinicalTrials.gov with Loma Linda University as lead sponsor.

NCT NCT05551104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05551104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safest Choice of Antihypertensive Regimen for Postpartum Hypertension: A Randomized Control Trial (SCARPH)
Lead sponsor
Loma Linda University
Phase
Phase 3
Overall status
Recruiting
Start date
May 8, 2023
Completion date
December 31, 2027
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high blood pressure, maternal hypertension, postpartum complication